Article summary
Research Plan on Bear Bile Medicine Is Hailed by Animal Activists
Shanghai Kaibao Pharmaceutical, which is listed on the Shenzhen Stock Exchange, told investors that its project to develop a bear bile equivalent from poultry bile had the support of the Chinese Ministry of Science and Technology. Kaibao said the central government had promised a grant of more than 5.3 million renminbi, but that it had not yet received the grant, and that local authorities had pledged 6 million renminbi. Animal welfare groups welcomed the research, though Animals Asia founder Jill Robinson said the synthetic product is still an animal product. The article notes that bears are the only mammal that produces large amounts of ursodeoxycholic acid, and that manufacturers outside China already make it from cattle or bird bile.
Read the original on Sinosphere Blog Archived copy
Omnifeed summarized this article with AI from its text (an archived copy), checked . Omnifeed isn’t affiliated with Sinosphere Blog. How we use AI